Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial
- Status
- COMPLETED
- Phase
- PHASE3
Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2